Developing countries stand to profit most from advances in genome science, write Samuel Broder, Stephen Hoffman and Peter Hotez in this month’s issue of EMBO reports (EMBO reports September, 2002 pp 806–812). They claim that biotechnology coupled with genomics might emerge as the key technology in the 21st century for improving global health and probably even avoiding major political conflicts and wars.

The authors warn that we must no longer view the diseases of the developing world in

Pilot project for stroke victims to begin this fall

A Queen’s neuroscientist’s invention to help understand the role of the brain in arm and leg movement will dramatically improve the assessment and rehabilitation of stroke and spinal cord victims. It will also help lay the groundwork for development of neural prostheses that can re-activate paralyzed limbs.

Dr. Stephen Scott’s unique mathematical model, combined with his new experimental device, KINARM (Kines

A research project to restore native grasslands to a reserve in California has yielded some promising results. The native grasslands may only need to be reseeded with native seeds without having to first eradicate the invading plants from Europe, according to a presentation at the recent annual Ecological Society of America meeting by researchers from the University of California, Santa Barbara and the University of Minnesota.

The research team included Eric Seabloom, of the National Center

Instead of landfills clogged with computer and car parts, packaging and a myriad of other plastic parts, a Cornell University fiber scientist has a better idea. In coming years, he says, many of these discarded items will be composted.

The key to this “green” solution, says researcher Anil Netravali, is fully biodegradable composites made from soybean protein and other biodegradable plastics and plant-based fibers, developed at Cornell and elsewhere.

“These new fully biodegradable

Another piece of the complex puzzle of how inflammation is involved in heart attacks and strokes has been discovered by researchers at the University of California, San Diego (UCSD) School of Medicine.

Their findings demonstrate that C-reactive protein (CRP) binds to oxidized low density lipoprotein (LDL), implicating the interaction of CRP and oxidized LDL as a potential trigger for the cascade of events leading to atherosclerosis. This form of artery disease is characterized by the buildup

Scientists from the University of Edinburgh are using immune cells harvested from blood donors to help fight an unusual cancer which can affect transplant patients. And their findings, published recently in The Lancet show that the therapy has proved effective in a number of cases. The treatment proved successful last year in saving the life of a four-year-old boy from Birmingham, who developed the cancer— post-transplant lympho-proliferative disease— following a liver and bowel transplant.